Prolaris Test Predicts Which PC Patients Benefit from Combo Therapy, Study Finds
News
Myriad Genetics’ Prolaris — a genetic test that predicts the aggressiveness of prostate cancer — can identify which men with intermediate or high-risk prostate cancer will benefit from combining androgen ... Read more